Low-dose mithramycin exerts its anticancer effect via the p53 signaling pathway and synergizes with nutlin-3 in gynecologic cancers

Tatsuhiro Ohgami, Kiyoko Kato, Hiroaki Kobayashi, Kenzo Sonoda, Takafumi Inoue, Shin ichiro Yamaguchi, Tomoko Yoneda, Norio Wake

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Fingerprint Dive into the research topics of 'Low-dose mithramycin exerts its anticancer effect via the p53 signaling pathway and synergizes with nutlin-3 in gynecologic cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences